FINWIRES · TerminalLIVE
FINWIRES

InSilico Medicine, CMS Expand Drug Development Partnership

By

InSilico Medicine (HKG:3696) expanded its collaboration with China Medical System (HKG:0867, SGX:8A8) to jointly develop innovative drugs for central nervous system diseases, according to a Monday filing with the Hong Kong bourse.

Under the agreement, InSilico will combine its artificial intelligence drug discovery platform with CMS' research and development capabilities and therapeutic expertise to advance the programs.

InSilico said it is eligible to receive milestone payments of up to 1.20 billion yuan, plus royalties based on net sales under the collaboration.

Related Articles

Asia

GAC Warns of Wider Loss in H1

Guangzhou Automobile Group or GAC (HKG:2238, SHA:601238) expects an attributable loss of between 4.06 billion yuan and 4.57 billion yuan for the first half of 2026, wider than 2.54 billion yuan a year prior.The automaker attributed the forecast to a wider loss from self-developed brands, lower investment income, and foreign exchange losses, according to a Friday Hong Kong bourse filing.

HKG:2238SHA:601238
Asia

Jiumaojiu International Posts Mixed Same-Store Daily Sales in Q2

Jiumaojiu International Holdings (HKG:9922) posted mixed results for same-store average daily sales across major brands in the second quarter of 2026, according to a Friday Hong Kong bourse filing.Self-operated Tai Er stores recorded a 6.1% rise in same-store average daily sales. On the other hand, Song Hot Pot fell 26% and Jiu Mao Jiu declined 14%.As of June 30, Jiumaojiu operated 606 restaurants, including 477 Tai Er outlets.Average spending per customer across major brands has remained relatively stable for several consecutive quarters.

HKG:9922
Asia

CSSC Offshore & Marine Engineering Forecasts Up to 69% Surge in H1 Profit

CSSC Offshore & Marine Engineering (HKG:0317, SHA:600685) expects an attributable profit of between 790 million yuan and 890 million yuan for the first half of 2026, up 50% to 69% from 526.4 million yuan a year prior.The marine and defense equipment manufacturer attributed the forecast to a rise in product gross profit amid production and operational efficiency, as well as higher recognized investment income.

HKG:0317SHA:600685